Combined Modality Therapy for Lymph Node Positive Prostate Cancer
![](https://academy.astro.org/sites/default/files/styles/course_image_teaser/public/OnlineCourses.jpg?itok=VNNiGZcY)
Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.
Category
- Genitourinary Cancer
Format
- CME only
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance